LENZ Therapeutics Management
Management criteria checks 1/4
LENZ Therapeutics' CEO is Eef Schimmelpennink, appointed in Mar 2021, has a tenure of 3.17 years. total yearly compensation is $2.52M, comprised of 21.3% salary and 78.7% bonuses, including company stock and options. directly owns 3.08% of the company’s shares, worth $14.65M. The average tenure of the management team and the board of directors is 1.6 years and 0.2 years respectively.
Key information
Eef Schimmelpennink
Chief executive officer
US$2.5m
Total compensation
| CEO salary percentage | 21.3% |
| CEO tenure | 3.2yrs |
| CEO ownership | 3.1% |
| Management average tenure | 1.6yrs |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$74m |
| Dec 31 2023 | US$3m | US$537k | -US$70m |
| Sep 30 2023 | n/a | n/a | -US$56m |
| Dec 31 2022 | US$1m | US$508k | -US$11m |
Compensation vs Market: Eef's total compensation ($USD2.52M) is about average for companies of similar size in the US market ($USD2.41M).
Compensation vs Earnings: Eef's compensation has increased whilst the company is unprofitable.
CEO
Eef Schimmelpennink (51 yo)
3.2yrs
Tenure
US$2,517,407
Compensation
Mr. Evert B. Schimmelpennink, also known as Eef, serves as Director of Pipeline Therapeutics, Inc. since February 2022. He serves as an Independent Director at Contineum Therapeutics, Inc. since January 20...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.2yrs | US$2.52m | 3.08% $ 14.6m | |
| Chief Commercial Officer | 3.1yrs | US$795.02k | 0.58% $ 2.8m | |
| Chief Medical Officer | less than a year | US$920.16k | 0.39% $ 1.9m | |
| Co-Founder & Director | no data | no data | 2.43% $ 11.6m | |
| Senior Scientific Advisor & Founder | no data | no data | no data | |
| Chief Financial Officer | less than a year | no data | 0.012% $ 59.4k | |
| Vice President of Sales | no data | no data | no data | |
| Senior Director of Marketing & Alliance Development | no data | no data | no data | |
| Senior Vice President of Regulatory & Quality | no data | no data | no data |
1.6yrs
Average Tenure
57.5yo
Average Age
Experienced Management: LENZ's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | no data | US$2.52m | 3.08% $ 14.6m | |
| Co-Founder & Director | less than a year | no data | 2.43% $ 11.6m | |
| Independent Director | less than a year | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Chairman | less than a year | no data | no data | |
| Independent Director | 3.3yrs | no data | 0.15% $ 704.1k | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | no data | no data |
0.2yrs
Average Tenure
50.5yo
Average Age
Experienced Board: LENZ's board of directors are not considered experienced ( 0.2 years average tenure), which suggests a new board.